Predictive impact of soluble interleukin‐2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B‐cell lymphoma

There remains an unmet clinical need to identify which patients with diffuse large B‐cell lymphoma (DLBCL) would benefit from central nervous system (CNS) prophylaxis, due to the low positive predictive value (PPV; 10%–15%) of the currently available predictive models. To stratify patients at high r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shichijo, Takafumi, Tatetsu, Hiro, Nosaka, Kisato, Higuchi, Yusuke, Kikukawa, Yoshitaka, Inoue, Yoshitaka, Toyoda, Kosuke, Yasunaga, Jun‐ichirou, Matsuoka, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Haematologic Malignancy ‐ Lymphoid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175809/
https://www.ncbi.nlm.nih.gov/pubmed/35846027
http://dx.doi.org/10.1002/jha2.393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175809/
https://www.ncbi.nlm.nih.gov/pubmed/35846027
http://dx.doi.org/10.1002/jha2.393

Ejemplares similares